Cocaine-Induced Endocannabinoid Mobilization in the Ventral Tegmental Area

Cell Reports

Volumn 12, Issue 12, 2015, Pages 1997-2008

  Wang, Huikun ^a   Treadway, Tyler ^a   Covey, Daniel P ^b   Cheer, Joseph F ^b   Lupica, Carl R ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ALPHA 1 ADRENERGIC RECEPTOR; CALCIUM; CANNABINOID 1 RECEPTOR; COCAINE; DOPAMINE; ENDOCANNABINOID; METABOTROPIC RECEPTOR 1; NORADRENALIN; PHOSPHOLIPASE C; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; ACYLGLYCEROL; ARACHIDONIC ACID DERIVATIVE; DOPAMINE UPTAKE INHIBITOR; GLYCERYL 2-ARACHIDONATE; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; METABOTROPIC RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM SIGNALING; COCAINE DEPENDENCE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; ENZYME ACTIVATION; FEMALE; GABAERGIC SYSTEM; IN VIVO STUDY; MALE; MESENCEPHALON; MOLECULAR MECHANICS; NONHUMAN; NORADRENALIN UPTAKE; NUCLEUS ACCUMBENS; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; PROTEIN TRANSPORT; RAT; REWARD; VENTRAL TEGMENTUM; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; SECRETION (PROCESS); SPRAGUE DAWLEY RAT; SYNAPTIC TRANSMISSION; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; ARACHIDONIC ACIDS; BIOLOGICAL TRANSPORT; CALCIUM; COCAINE; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; DOPAMINERGIC NEURONS; ENDOCANNABINOIDS; GAMMA-AMINOBUTYRIC ACID; GENE EXPRESSION REGULATION; GLYCERIDES; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; MALE; NOREPINEPHRINE; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, GABA; RECEPTORS, METABOTROPIC GLUTAMATE; REWARD; SYNAPTIC TRANSMISSION; TYPE C PHOSPHOLIPASES; VENTRAL TEGMENTAL AREA;

EID: 84942826205     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.08.041     Document Type: Article

References (57)

1. Alger B.E., Kim J. Supply and demand for endocannabinoids. Trends Neurosci. 2011, 34:304-315.
2. Aragona B.J., Cleaveland N.A., Stuber G.D., Day J.J., Carelli R.M., Wightman R.M. Preferential enhancement of dopamine transmission within the nucleus accumbens shell by cocaine is attributable to a direct increase in phasic dopamine release events. J. Neurosci. 2008, 28:8821-8831.
3. Auclair A., Cotecchia S., Glowinski J., Tassin J.P. D-amphetamine fails to increase extracellular dopamine levels in mice lacking alpha 1b-adrenergic receptors: relationship between functional and nonfunctional dopamine release. J. Neurosci. 2002, 22:9150-9154.
4. Cameron D.L., Williams J.T. Cocaine inhibits GABA release in the VTA through endogenous 5-HT. J. Neurosci. 1994, 14:6763-6767.
5. Cheer J.F., Wassum K.M., Sombers L.A., Heien M.L.A.V., Ariansen J.L., Aragona B.J., Phillips P.E.M., Wightman R.M. Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation. J. Neurosci. 2007, 27:791-795.
6. Chieng B., Azriel Y., Mohammadi S., Christie M.J. Distinct cellular properties of identified dopaminergic and GABAergic neurons in the mouse ventral tegmental area. J. Physiol. 2011, 589:3775-3787.
7. Cooper D.C. The significance of action potential bursting in the brain reward circuit. Neurochem. Int. 2002, 41:333-340.
8. Covey D.P., Roitman M.F., Garris P.A. Illicit dopamine transients: reconciling actions of abused drugs. Trends Neurosci. 2014, 37:200-210.
9. De Vries T.J., Shaham Y., Homberg J.R., Crombag H., Schuurman K., Dieben J., Vanderschuren L.J., Schoffelmeer A.N. A cannabinoid mechanism in relapse to cocaine seeking. Nat. Med. 2001, 7:1151-1154.
10. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992, 258:1946-1949.
11. Di Chiara G., Bassareo V. Reward system and addiction: what dopamine does and doesn't do. Curr. Opin. Pharmacol. 2007, 7:69-76.
12. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA 1988, 85:5274-5278.
13. Einhorn L.C., Johansen P.A., White F.J. Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: studies in the ventral tegmental area. J. Neurosci. 1988, 8:100-112.
14. Fiorillo C.D., Williams J.T. Glutamate mediates an inhibitory postsynaptic potential in dopamine neurons. Nature 1998, 394:78-82.
15. French E.D., Dillon K., Wu X. Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra. Neuroreport 1997, 8:649-652.
16. Gessa G.L., Melis M., Muntoni A.L., Diana M. Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors. Eur. J. Pharmacol. 1998, 341:39-44.
17. Goertz R.B., Wanat M.J., Gomez J.A., Brown Z.J., Phillips P.E., Paladini C.A. Cocaine increases dopaminergic neuron and motor activity via midbrain α1 adrenergic signaling. Neuropsychopharmacology 2014, Published online November 6, 2014. 10.1038/npp.2014.296.
18. Hashimotodani Y., Ohno-Shosaku T., Tsubokawa H., Ogata H., Emoto K., Maejima T., Araishi K., Shin H.S., Kano M. Phospholipase Cbeta serves as a coincidence detector through its Ca2+ dependency for triggering retrograde endocannabinoid signal. Neuron 2005, 45:257-268.
19. Hashimotodani Y., Ohno-Shosaku T., Kano M. Ca(2+)-assisted receptor-driven endocannabinoid release: mechanisms that associate presynaptic and postsynaptic activities. Curr. Opin. Neurobiol. 2007, 17:360-365.
20. Hoffman A.F., Lupica C.R. Synaptic targets of δ9-tetrahydrocannabinol in the central nervous system. Cold Spring Harb. Perspect. Med. 2013, 3:a012203.
21. Hurst D., Umejiego U., Lynch D., Seltzman H., Hyatt S., Roche M., McAllister S., Fleischer D., Kapur A., Abood M., et al. Biarylpyrazole inverse agonists at the cannabinoid CB1 receptor: importance of the C-3 carboxamide oxygen/lysine3.28(192) interaction. J. Med. Chem. 2006, 49:5969-5987.
22. Jones B.E., Halaris A.E., McIlhany M., Moore R.Y. Ascending projections of the locus coeruleus in the rat. I. Axonal transport in central noradrenaline neurons. Brain Res. 1977, 127:1-21.
23. Kalivas P.W., Duffy P. D1 receptors modulate glutamate transmission in the ventral tegmental area. J. Neurosci. 1995, 15:5379-5388.
24. Kano M., Ohno-Shosaku T., Hashimotodani Y., Uchigashima M., Watanabe M. Endocannabinoid-mediated control of synaptic transmission. Physiol. Rev. 2009, 89:309-380.
25. Kim J., Isokawa M., Ledent C., Alger B.E. Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus. J. Neurosci. 2002, 22:10182-10191.
26. Kortleven C., Fasano C., Thibault D., Lacaille J.C., Trudeau L.E. The endocannabinoid 2-arachidonoylglycerol inhibits long-term potentiation of glutamatergic synapses onto ventral tegmental area dopamine neurons in mice. Eur. J. Neurosci. 2011, 33:1751-1760.
27. Koulchitsky S., De Backer B., Quertemont E., Charlier C., Seutin V. Differential effects of cocaine on dopamine neuron firing in awake and anesthetized rats. Neuropsychopharmacology 2012, 37:1559-1571.
28. Kreitzer A.C., Regehr W.G. Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron 2001, 29:717-727.
29. Landsman R.S., Burkey T.H., Consroe P., Roeske W.R., Yamamura H.I. SR141716A is an inverse agonist at the human cannabinoid CB1 receptor. Eur. J. Pharmacol. 1997, 334:R1-R2.
30. Li X., Hoffman A.F., Peng X.Q., Lupica C.R., Gardner E.L., Xi Z.X. Attenuation of basal and cocaine-enhanced locomotion and nucleus accumbens dopamine in cannabinoid CB1-receptor-knockout mice. Psychopharmacology (Berl.) 2009, 204:1-11.
31. Lupica C.R., Riegel A.C. Endocannabinoid release from midbrain dopamine neurons: a potential substrate for cannabinoid receptor antagonist treatment of addiction. Neuropharmacology 2005, 48:1105-1116.
32. Lupica C.R., Riegel A.C., Hoffman A.F. Marijuana and cannabinoid regulation of brain reward circuits. Br. J. Pharmacol. 2004, 143:227-234.
33. Maejima T., Hashimoto K., Yoshida T., Aiba A., Kano M. Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors. Neuron 2001, 31:463-475.
34. Maejima T., Oka S., Hashimotodani Y., Ohno-Shosaku T., Aiba A., Wu D., Waku K., Sugiura T., Kano M. Synaptically driven endocannabinoid release requires Ca2+-assisted metabotropic glutamate receptor subtype 1 to phospholipase Cbeta4 signaling cascade in the cerebellum. J. Neurosci. 2005, 25:6826-6835.
35. Mátyás F., Urbán G.M., Watanabe M., Mackie K., Zimmer A., Freund T.F., Katona I. Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area. Neuropharmacology 2008, 54:95-107.
36. Mechoulam R., Ben-Shabat S., Hanus L., Ligumsky M., Kaminski N.E., Schatz A.R., Gopher A., Almog S., Martin B.R., Compton D.R., et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 1995, 50:83-90.
37. Mejías-Aponte C.A., Drouin C., Aston-Jones G. Adrenergic and noradrenergic innervation of the midbrain ventral tegmental area and retrorubral field: prominent inputs from medullary homeostatic centers. J. Neurosci. 2009, 29:3613-3626.
38. Mejias-Aponte C.A., Ye C., Bonci A., Kiyatkin E.A., Morales M. A subpopulation of neurochemically-identified ventral tegmental area dopamine neurons is excited by intravenous cocaine. J. Neurosci. 2015, 35:1965-1978.
39. Melis M., Pistis M., Perra S., Muntoni A.L., Pillolla G., Gessa G.L. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. J. Neurosci. 2004, 24:53-62.
40. Ohno-Shosaku T., Maejima T., Kano M. Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron 2001, 29:729-738.
41. Oleson E.B., Beckert M.V., Morra J.T., Lansink C.S., Cachope R., Abdullah R.A., Loriaux A.L., Schetters D., Pattij T., Roitman M.F., et al. Endocannabinoids shape accumbal encoding of cue-motivated behavior via CB1 receptor activation in the ventral tegmentum. Neuron 2012, 73:360-373.
42. Pan B., Hillard C.J., Liu Q.-S. Endocannabinoid signaling mediates cocaine-induced inhibitory synaptic plasticity in midbrain dopamine neurons. J. Neurosci. 2008, 28:1385-1397.
43. Phillips P.E.M., Stuber G.D., Heien M.L.A.V., Wightman R.M., Carelli R.M. Subsecond dopamine release promotes cocaine seeking. Nature 2003, 422:614-618.
44. Reith M.E., Li M.Y., Yan Q.S. Extracellular dopamine, norepinephrine, and serotonin in the ventral tegmental area and nucleus accumbens of freely moving rats during intracerebral dialysis following systemic administration of cocaine and other uptake blockers. Psychopharmacology (Berl.) 1997, 134:309-317.
45. Riegel A.C., Lupica C.R. Independent presynaptic and postsynaptic mechanisms regulate endocannabinoid signaling at multiple synapses in the ventral tegmental area. J. Neurosci. 2004, 24:11070-11078.
46. Ritz M.C., Lamb R.J., Goldberg S.R., Kuhar M.J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 1987, 237:1219-1223.
47. Roitman M.F., Stuber G.D., Phillips P.E.M., Wightman R.M., Carelli R.M. Dopamine operates as a subsecond modulator of food seeking. J. Neurosci. 2004, 24:1265-1271.
48. Sombers L.A., Beyene M., Carelli R.M., Wightman R.M. Synaptic overflow of dopamine in the nucleus accumbens arises from neuronal activity in the ventral tegmental area. J. Neurosci. 2009, 29:1735-1742.
49. Soria G., Mendizábal V., Touriño C., Robledo P., Ledent C., Parmentier M., Maldonado R., Valverde O. Lack of CB1 cannabinoid receptor impairs cocaine self-administration. Neuropsychopharmacology 2005, 30:1670-1680.
50. Steinberg E.E., Boivin J.R., Saunders B.T., Witten I.B., Deisseroth K., Janak P.H. Positive reinforcement mediated by midbrain dopamine neurons requires D1 and D2 receptor activation in the nucleus accumbens. PLoS ONE 2014, 9:e94771.
51. Sulzer D. How addictive drugs disrupt presynaptic dopamine neurotransmission. Neuron 2011, 69:628-649.
52. Szabo B., Siemes S., Wallmichrath I. Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids. Eur. J. Neurosci. 2002, 15:2057-2061.
53. Thomsen M., Han D.D., Gu H.H., Caine S.B. Lack of cocaine self-administration in mice expressing a cocaine-insensitive dopamine transporter. J. Pharmacol. Exp. Ther. 2009, 331:204-211.
54. Wilson R.I., Nicoll R.A. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 2001, 410:588-592.
55. Wise R.A., Rompre P.P. Brain dopamine and reward. Annu. Rev. Psychol. 1989, 40:191-225.
56. Xi Z.X., Gilbert J.G., Peng X.Q., Pak A.C., Li X., Gardner E.L. Cannabinoid CB1 receptor antagonist AM251 inhibits cocaine-primed relapse in rats: role of glutamate in the nucleus accumbens. J. Neurosci. 2006, 26:8531-8536.
57. Xi Z.X., Spiller K., Pak A.C., Gilbert J., Dillon C., Li X., Peng X.Q., Gardner E.L. Cannabinoid CB1 receptor antagonists attenuate cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats. Neuropsychopharmacology 2008, 33:1735-1745.